Back to all Press

Drug and Device Development Outsourcing 2.0 - Soaring Beyond the CRO

January 9, 2023

ProPharma Group - the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries launched the Research Consulting Organization (RCO) model, a new type of research consulting and clinical service for biotech, pharma and device innovators to deliver bespoke solutions that bring life-saving drugs to market sooner and more cost effectively.


 

Download the Whitepaper
Company News



Related Articles

Press Releases Brian Katz, Chief Strategy Officer (CSO) / Head of Corporate Development

September 13, 2022

ProPharma announces the appointment of Bryan Katz as new Chief Strategy Officer (CSO) / Head of Corporate Development

ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the expansion of the senior leadership team to include Bryan Katz as the new Chief Strategy Officer (CSO) / Head...

Read the Full Article
Company News

July 1, 2021

Former Deputy Director of Diagnostics, Bill and Melinda Gates Foundation, Joins NDA Partners as Expert Consultant

NDA Partners President Earle Martin announced today that Cristina Giachetti, PhD, former Deputy Director of Diagnostics at the Bill and Melinda Gates Foundation, has joined the firm as an Expert...

Read the Full Article
Press Releases Karl Deonanan, ProPharma Chief Financial Officer (CFO)

March 1, 2023

ProPharma Announces the Appointment of Karl Deonanan as New Chief Financial Officer

Raleigh, NC, March 1, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and quality services for the life sciences industry and a portfolio company of Odyssey...

Read the Full Article